Literature DB >> 2113641

Renal involvement in Churg-Strauss syndrome.

E J Clutterbuck1, D J Evans, C D Pusey.   

Abstract

Churg-Strauss syndrome is part of the spectrum of systemic vasculitis, but can be distinguished from the other necrotising vasculitides on the basis of clinical and histological criteria. Renal involvement is not regarded as a prominent feature and is generally mild. We report a series of 19 patients with Churg-Strauss syndrome referred to the Hammersmith Hospital between 1976 and 1986. Renal involvement was common (84%) and often severe: three patients had nephrotic syndrome; four presented with serum creatinine greater than 500 mumol/l; and two required dialysis. Focal segmental glomerulonephritis was the predominant lesion on biopsy (85%), often with necrotising features and crescent formation. Extravascular granulomata and eosinophilic infiltrates were uncommon. Treatment with high-dose prednisolone was generally successful in milder cases, but was not always sufficient to halt the progression of more severe vasculitis. In these cases, additional immunosuppressive therapy with azathioprine, cyclophosphamide or plasma exchange was of benefit. Renal disease improved in 14 of 16 patients, ten of whom have maintained normal renal function on follow-up. Only one patient died, as a result of progressive cardiac disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2113641     DOI: 10.1093/ndt/5.3.161

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  11 in total

Review 1.  New horizons in renal vasculitis.

Authors:  J S Cameron
Journal:  Klin Wochenschr       Date:  1991-09-03

2.  Anti-myeloperoxidase antibodies in Churg-Strauss syndrome.

Authors:  J W Tervaert; C G Kallenberg
Journal:  J Neurol       Date:  1993-07       Impact factor: 4.849

3.  Cholesterol emboli may mimic systemic vasculitis.

Authors:  D S Peat; P W Mathieson
Journal:  BMJ       Date:  1996-08-31

4.  [A 32-year-old patient with diarrhoea and acute kidney failure].

Authors:  A Hoffmeister; H Wittenburg; N Teich; A Bachmann; G Borte; J Mössner; H Achenbach
Journal:  Internist (Berl)       Date:  2006-10       Impact factor: 0.743

5.  Rituximab for the treatment of Churg-Strauss syndrome with renal involvement.

Authors:  Rodrigo Cartin-Ceba; Karina A Keogh; Ulrich Specks; Sanjeev Sethi; Fernando C Fervenza
Journal:  Nephrol Dial Transplant       Date:  2011-02-16       Impact factor: 5.992

Review 6.  Vasculitis in childhood.

Authors:  I Roberti; L Reisman; J Churg
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

7.  A case of nephrotic syndrome in a patient with Churg-Strauss syndrome.

Authors:  Sun Young Park; Jae Hyun Chang; Hyun-Wook Kim; Dong Ki Kim; Eun Young Kim; Jung Tak Park; Tae Ik Chang; Jung Won Park; Hyeon Joo Jeong; Dae-Suk Han; Shin-Wook Kang
Journal:  Rheumatol Int       Date:  2009-08-21       Impact factor: 2.631

Review 8.  Clinical review: Vasculitis on the intensive care unit -- part 2: treatment and prognosis.

Authors:  David Semple; James Keogh; Luigi Forni; Richard Venn
Journal:  Crit Care       Date:  2004-08-18       Impact factor: 9.097

Review 9.  Clinical review: Vasculitis on the intensive care unit--part 1: diagnosis.

Authors:  David Semple; James Keogh; Luigi Forni; Richard Venn
Journal:  Crit Care       Date:  2004-08-18       Impact factor: 9.097

10.  The Churg-Strauss syndrome: An unusual presentation.

Authors:  G K Manu; A Mathew; R Rajesh; G Kurian; V N Unni; G S Pillai; K R Hiran
Journal:  Indian J Nephrol       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.